Beginner's Mind

#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

April 01, 2020 Season 1 Episode 9
Beginner's Mind
#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed
Chapters
Beginner's Mind
#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed
Apr 01, 2020 Season 1 Episode 9

These days there is a lot of discussion about the development of diagnostics, therapeutics, and vaccines against the Coronavirus and it´s disease COVID 19. Viruses are one threat to the health of human beings. Bacteria is another one. Traditionally, bacterial infections are treated with antibiotics. Recently, some bacteria have developed antibiotic resistance.

The WHO describes that Antibiotic resistance is one of the biggest threats to global health, food security, and development today. (https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance)

Phagomed (https://www.phagomed.com/) is developing a novel approach to treat bacterial infections without antibiotics. How that works, the challenges a company has to face during the development of novel drugs, and why not all viruses are evil, you will hear in this episode.

More information: 

https://www.phagomed.com/
https://www.lifescienceget2gether.com/
https://linktr.ee/soschner

Show Notes

These days there is a lot of discussion about the development of diagnostics, therapeutics, and vaccines against the Coronavirus and it´s disease COVID 19. Viruses are one threat to the health of human beings. Bacteria is another one. Traditionally, bacterial infections are treated with antibiotics. Recently, some bacteria have developed antibiotic resistance.

The WHO describes that Antibiotic resistance is one of the biggest threats to global health, food security, and development today. (https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance)

Phagomed (https://www.phagomed.com/) is developing a novel approach to treat bacterial infections without antibiotics. How that works, the challenges a company has to face during the development of novel drugs, and why not all viruses are evil, you will hear in this episode.

More information: 

https://www.phagomed.com/
https://www.lifescienceget2gether.com/
https://linktr.ee/soschner